Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cureus|May 15, 2025
Reassessing Cisplatin Eligibility in Urothelial Carcinoma: A Retrospective Study on Dose Reduction StrategiesSatoshi Yamamoto, Koichiro Kurokawa, Koki Watanabe, et al.
Anticancer Research|February 27, 2026
Severe Esophageal Ulceration With Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Case ReportHiroki Bamba, Satoshi Yamamoto, Keita Higa, et al.
Geriatrics & Gerontology International|July 31, 2026
Full-Component Chart-Derived Lee Score, Upfront Androgen Receptor Signaling Inhibitor Selection, and Competing Mortality in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Keita Higa, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 13, 2025
Prognostic significance of nutritional and muscular indices in immune checkpoint inhibitor therapy for metastatic urothelial carcinoma: A preliminary studySatoshi Yamamoto, Keita Higa, Koichiro Kurokawa, et al.
International Urology and Nephrology|April 3, 2026
Tumor-draining lymph nodes as immunologic hubs: rethinking nodal surgery in the era of checkpoint blockade in urologic cancersSatoshi Yamamoto, Keita Higa, Koichiro Kurokawa, et al.
Cancer Genetics|June 17, 2025
Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancerKeita Higa, Satoshi Yamamoto, Koichiro Kurokawa, et al.
The Prostate|September 10, 2023
Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort studyYasutaka Yamada, Shinichi Sakamoto, Kodai Sato, et al.
Scientific Reports|January 10, 2024
Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeonMasafumi Maruo, Yusuke Goto, Kanetaka Miyazaki, et al.
Scientific Reports|June 27, 2024
Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomyKoichiro Kurokawa, Yasutaka Yamada, Shinichi Sakamoto, et al.
The Prostate|March 31, 2026
A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate CancerKoichiro Kurokawa, Satoshi Yamamoto, Yasutaka Yamada, et al.
Pageof 1